S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

PEPG PepGen Inc

3.364

1.99 (145.55%)

Last Updated: 09:32:42

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

PepGen (NASDAQ:PEPG)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more PepGen Charts.

PepGen (NASDAQ:PEPG)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more PepGen Charts.

PepGen Inc News

Form 8-K - Current report
Monday 24 February 2025 (3 hours ago) • Edgar (US Regulatory)

PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights
Monday 24 February 2025 (3 hours ago) • Business Wire

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Monday 24 February 2025 (4 hours ago) • Edgar (US Regulatory)

PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1
Monday 24 February 2025 (4 hours ago) • Business Wire

Form 8-K - Current report
Wednesday 29 January 2025 (4 weeks ago) • Edgar (US Regulatory)

PepGen Announces CONNECT Program Updates
Wednesday 29 January 2025 (4 weeks ago) • Business Wire

Form 8-K - Current report
Monday 16 December 2024 (2 months ago) • Edgar (US Regulatory)

PepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51 for Duchenne Muscular Dystrophy
Monday 16 December 2024 (2 months ago) • Business Wire

PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development
Thursday 21 November 2024 (3 months ago) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (4 months ago) • Edgar (US Regulatory)

PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Thursday 7 November 2024 (4 months ago) • Business Wire

More PepGen Inc News Articles

Valiant Eagle (PK)

Intergrated Cannabis Sol... (PK)

Accredited Solutions (PK)

Adia Nutrition (PK)

Northwest Biotherapeutics (QB)

Lightwave Logic

Anavex Life Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions